Movement Disorders and Inherited Metabolic Disorders

Darius Ebrahimi-Fakhari is a Physician-Scientist at the Department of Neurology at Boston Children's Hospital. He is the recipient of the Outstanding Junior Member Award from the Child Neurology Society and the Young Investigator Award from the German Society for Pediatric Neurology. Phillip L. Pearl is the William G. Lennox Chair and Professor of Neurology at Harvard Medical School and Director of Epilepsy and Clinical Neurophysiology at Boston Children's Hospital. He is the Past President of the Professors of Child Neurology and President-Elect of the Child Neurology Society. He is the editor of Inherited Metabolic Epilepsies (2018) and several other textbooks.

• Section I. General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders: 1. Treatable Metabolic Movement Disorders: the Top 10; 2. The Importance of Movement Disorders in Inborn Errors of Metabolism; 3. The Importance of Inborn Errors of Metabolism for Movement Disorders; 4. Imaging in Metabolic Movement Disorders; 5. Biochemical Testing for Metabolic Movement Disorders; 6. Genetic Testing for Metabolic Movement Disorders; 7. A Phenomenology-Based approach to inborn errors of metabolism with Ataxia; 8. A Phenomenology-Based Approach to Inborn Errors of Metabolism with Dystonia; 9. A Phenomenology-Based Approach to Inborn Errors of Metabolism with Parkinsonism; 10. A Phenomenology-Based Approach to Inborn Errors of Metabolism with Spasticity; 11. A Phenomenology-Based Approach to Inborn Errors of Metabolism with Myoclonus; Section II. A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders: 12. Disorders of Amino Acid Metabolism: Amino Acid Disorders, Organic Acidurias, and Urea Cycle Disorders with Movement Disorders; 13. Disorders of Energy Metabolism: Glut1 Deficiency Syndrome and Movement Disorders; 14. Lysosomal Storage Disorders: Niemann-Pick Disease Type C and Movement Disorders; 15. Lysosomal Storage Disorders: Neuronal Ceroid Lipofuscinoses and Movement Disorders; 16. Syndromes of Neurodegeneration with Brain Iron Accumulation; 17. Metal Storage Disorders: Inherited Disorders of Copper and Manganese Metabolism and Movement Disorders; 18. Metal Storage Disorders: Primary Familial brain Calcification and Movement Disorders; 19. Disorders of Glycosylation and Movement Disorders; 20. Disorders of Post-translational Modifications / Degradation: Disorders of Autophagy and Movement Disorders; 21. Neurotransmitter Disorders: Disorders of Dopamine Metabolism and Movement Disorders; 22. Disorders of GABA Metabolism and Movement Disorders; 23. DNAJC12-deficient Hyperphenylalaninemia – An Emerging Neurotransmitter Disorder; 24. Vitamin-Responsive Disorders: Ataxia with Vitamin E Deficiency and Movement Disorders; 25. Vitamin-Responsive Disorders: Biotin-Thiamin Responsive Basal Ganglia Disease and Movement Disorders; 26. Disorders of Cholesterol Metabolism: Cerebrotendinous Xanthomatosis and Movement Disorders; 27. Purine Metabolism Defects: the Movement Disorder of Lesch-Nyhan Disease; 28. Disorders of Creatine Metabolism: Creatine Deficiency Syndromes and Movement Disorders; 29. Hereditary Spastic Paraplegia Related Inborn Errors of Metabolism; Section III. Conclusions and Future Directions: 30. Metabolic Movement Disorders in the Era of Next-Generation Sequencing; 31. Deep Brain Stimulation for Metabolic Movement Disorders; 32. Novel Therapeutic Approaches to Metabolic Movement Disorders; Closing Remarks: A Clinical approach to Inherited Metabolic Movement Disorders.